Estrogen and Progesterone Receptor Determinations in Breast Cancer—Technology, Biology and Clinical Significance

Authors

  • S. M. Thorpe Fibiger Institute, Laboratory of Tumor Endocrinology and the University Department of Clinical Physiology and Nuclear Medicine, the Finsen Institute, Rigshospitalet, Copenhagen, Denmark

DOI:

https://doi.org/10.3109/02841868809090312

Keywords:

Breast cancer, ER, PgR, interlaboratory variation, biology, menopausal status, histopathology, prognosis

Abstract

While ER and PgR are gaining wide acceptance as significant prognostic factors in the treatment of breast cancer, other prognostic factors must be found in order to stage patients as accurately as possible at the time of the primary surgery so that the appropriate adjuvant treatment can be given to those patients at high risk of recurrent disease, and thus improve survival in breast cancer.

Downloads

Download data is not yet available.

Downloads

Published

1988-01-01

How to Cite

Thorpe, S. M. . (1988). Estrogen and Progesterone Receptor Determinations in Breast Cancer—Technology, Biology and Clinical Significance. Acta Oncologica, 27(1), 1–19. https://doi.org/10.3109/02841868809090312

Issue

Vol. 27 No. 1 (1988): Acta Oncologica

Section

Articles